Proton-pump inhibitors (PPIs) are frequently prescribed to suppress stomach acid in patients with gastroesophageal reflux disease (GERD). Prescribing rates of PPIs in children have risen more than 500 ...
For patients taking GLP-1 receptor agonists (GLP-1 RAs), the use of proton pump inhibitors (PPIs) is associated with an increased risk for gastrointestinal (GI) adverse effects, according to research ...
A large segment of the CYP2C19 rapid metabolizer subgroup is nonresponder to the PPI treatment, only partial symptom relief in GERD, more frequent unsuccessful eradication therapy and lower healing ...
Proton pump inhibitors are frequently used in neuro-oncology to reduce the risk of gastritis and peptic ulcer disease as a consequence of steroid use. In a meta-analysis, the use of proton pump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results